New research identifies a python-derived molecule, pTOS, that spikes after meals and may suppress appetite in mice. Could this lead to a new obesity drug with fewer side effects than current GLP-1 meds like Wegovy? We break down what the study found, how pTOS works in the brain, and what researchers still need to confirm before clinical use. Includes simple explanations, key takeaways, and potential implications for human metabolism.

Obesity Metabolism Biology Neuroscience GLP-1 Drug Discovery Nature Metabolism Python pTOS Burmese Python